Efficacy of Distant Healing in Glioblastoma Treatment

NCT00029783 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2006-08-18

No results posted yet for this study

Summary

This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.

Conditions

Interventions

PROCEDURE

Distant Healing

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • Andrew Freinkel, MD · California Pacific Medical Center Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Completion
2005-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00029783 on ClinicalTrials.gov